ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Merck in Talks to Buy Indian Pharmaceutical Ingredients Maker Micro Labs - Report

Merck & Co. Inc. (MRK) is in talks to acquire Indian active pharmaceutical ingredients maker Micro Labs Ltd., the Financial Express reported Thursday, citing an unidentified person aware of the matter. The newspaper said Bangalore-based Micro Labs is a privately held company, founded and run by the Surana family. Micro Labs aims to achieve sales of about $1 billion by 2015, the report said, citing the company's website. A Merck India spokesperson declined to comment to the newspaper on any possible deal. Newspaper website: http://www.financialexpress.com Write to djn.in@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
08/23/201603:03:00Deal for Medivation Is the Latest In a Line of Similar Acquisitions...
08/22/201612:52:00Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
08/10/201616:58:47Statement of Changes in Beneficial Ownership (4)
08/09/201603:03:00Botox Maker Allergan's Revenue Climbs, but Loss More Than Doubles...
08/08/201617:05:00Results from Merck’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir & g...
08/08/201616:41:16Quarterly Report (10-q)
08/08/201614:56:00Allergan Revenue Increases, Though Loss Widens--Update
08/08/201611:59:00MARKET SNAPSHOT: Stocks Retreat From Records As Health-care Stocks...
08/08/201610:20:00MARKET SNAPSHOT: Stocks Fight To Maintain Record-setting Pace...
08/08/201606:45:00REPEAT/FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Pa...
08/05/201619:30:00FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients wi...
08/05/201617:49:32Statement of Changes in Beneficial Ownership (4)
08/05/201612:58:00Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung Cancer...
08/05/201610:36:00Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung Cancer...
08/05/201610:15:00Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung Cancer...
08/05/201609:39:00Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung Cancer...
08/05/201609:20:00Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung Cancer...
08/05/201609:12:00Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung Cancer...
08/05/201608:00:00Merck Announces U.S. FDA Filing Acceptance of New Drug Application...
08/04/201614:30:37Statement of Changes in Beneficial Ownership (4)

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad